NCT01795339View on ClinicalTrials.gov

A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Elderly VolunteersMild-to-moderate Alzheimer's Disease Patients
Interventions
DRUG

AZD3293

Oral solution

DRUG

Placebo

Oral solution

Trial Locations (1)

Unknown

Research Site, Glendale

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY